Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bacci

Showing results (181-190 of 217) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997G Bacci, S Ferrari, A Longhi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992G Bacci, C Forni, A Longhi, et al.
Cancer Treatment and Research|January 1, 1993
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli InstituteG Bacci, P Picci, S Ferrari, et al.
Tumori|June 30, 1992
Osteosarcoma of the extremity metastatic at presentation: results achieved in 26 patients treated with combined therapy (primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions)G Bacci, P Picci, A Briccoli, et al.
Oncology Reports|February 15, 2000
Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamideG Bacci, A Briccoli, S Ferrari, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1991
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycinG Bacci, P Picci, P Ruggieri, et al.
Pediatric Blood & Cancer|January 15, 2009
Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcomaS Ferrari, A Brach del Prever, E Palmerini, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized studyG Bacci, F Gherlinzoni, P Picci, et al.
The New England Journal of Medicine|November 23, 1995
Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcomeN Baldini, K Scotlandi, G Barbanti-Bròdano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremitiesP Picci, B T Rougraff, G Bacci, et al.
Pageof 22

Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997G Bacci, S Ferrari, A Longhi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992G Bacci, C Forni, A Longhi, et al.
Cancer Treatment and Research|January 1, 1993
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli InstituteG Bacci, P Picci, S Ferrari, et al.
Tumori|June 30, 1992
Osteosarcoma of the extremity metastatic at presentation: results achieved in 26 patients treated with combined therapy (primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions)G Bacci, P Picci, A Briccoli, et al.
Oncology Reports|February 15, 2000
Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamideG Bacci, A Briccoli, S Ferrari, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1991
Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycinG Bacci, P Picci, P Ruggieri, et al.
Pediatric Blood & Cancer|January 15, 2009
Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcomaS Ferrari, A Brach del Prever, E Palmerini, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized studyG Bacci, F Gherlinzoni, P Picci, et al.
The New England Journal of Medicine|November 23, 1995
Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcomeN Baldini, K Scotlandi, G Barbanti-Bròdano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremitiesP Picci, B T Rougraff, G Bacci, et al.
Pageof 22